To read the full story, subscribe or sign in.

Leadership and equity issues explored at BIO CEO & Investor meeting

Feb. 17, 2021

In the opening panel of the BIO CEO & Investor digital conference BIO president and CEO Michelle McMurry-Heath explored some of the key issues that are currently impacting the sector with Adena Friedman, president and CEO of Nasdaq, which, this month, marks the 50th anniversary of its launch in 1971.

BioWorld Analysis and data insight Conferences BIO CEO

Free access to BioWorld coronavirus articles

BioWorld

The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus outbreak. Note that we have added three critical tables which are...

Today's news in brief

BioWorld

BioWorld briefs for July 5, 2022.

Novavax vaccine shows its chops

BioWorld

Given that Novavax Inc.’s COVID-19 vaccine will be a latecomer to the U.S. scene if it gets FDA authorization, it’s been cast in a supporting role to the lead...

Today's news in brief

BioWorld MedTech

BioWorld MedTech's briefs for July 5.

Biomarin outlines pricing strategy for costly hemophilia A gene therapy after backing from European regulators

BioWorld

The first gene therapy to treat severe hemophilia A was among the drugs recommended for European approval by regulators from the EMA’s CHMP at its monthly...

Upgrade your daily dose of biopharma and medtech news

Leadership and equity issues explored at BIO CEO & Investor meeting